Skip to main content

Bharat Immunological & Biological Corporation Share Price

15.95

0.00(0.00%)

Live Bharat Immunological & Biological Corporation Share Price Chart

Bharat Immunological & Biological Corporation Performance

Days Range

Previous Close₹15.95
Open₹16
Volume13,188
Day's Range₹15.75 - ₹16.09
52W Range₹14.10 - ₹23.19
Market Cap₹68.87 Cr

Bharat Immunological & Biological Corporation Fundamentals

ROCE(TTM)-11.16
P/E Ratio (TTM)-3.82
P/B RatioN/A
Industry P/E50.54
Debt to Equity0.94
ROE-22.95
EPS (TTM)N/A
Dividend YieldN/A
Book Value-7.54
Face Value10
ROCE(TTM)-11.16
P/E Ratio (TTM)-3.82
P/B RatioN/A
Industry P/E50.54
Debt to Equity0.94
ROE-22.95
EPS (TTM)N/A
Dividend YieldN/A
Book Value-7.54
Face Value10

Bharat Immunological & Biological Corporation Financials

Dec 2022Mar 2023Jun 2023Sep 2023
Net Sales0.007.650.000.00
Expenses4.7611.764.354.72
Profit before tax-6.33-5.68-5.97-6.65
Operating Profit-4.68-3.88-4.59-4.92
Net Profit-4.68-3.88-4.59-4.92
EPS in Rs-1.08-0.90-1.06-1.14

Bharat Immunological & Biological Corporation Shareholding Pattern

Promoters
59.25%
Retail And Others
40.75%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.00%

About Bharat Immunological & Biological Corporation

Incorporated in 1989 in Uttar Pradesh, Bharat Immunological & Biological Corporation (BIBCL) is in the business of manufacturing pharmaceutical formulations. The company's manufacturing unit is located in Bulandshahr district, Uttar Pradesh. BIBCL manufactures oral polio vaccine (OPV) for which it has installed a plant of 100 mln units. Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme. It has set up an R&D unit for the development of hepatitis B vaccine through transfer of technology from the US. The Company is planning to diversify into the production of vaccines pertaining to B.C.G, Measles and Tetanus Toxide.The company has been declared a SICK company by BIFR.

Parent Organisation
Govt of India
Managing Director
Sanjay Kumar Mishra
Founded
1989
NSE Symbol

Bharat Immunologicals Biologicals Corporation Share Price History

ParticularsDetails
5-Year % change in Bharat Immunologicals Biologicals Corporation share price28.21%
5-Year Highest in Bharat Immunologicals Biologicals Corporation share price₹ 94.5
5-Year Lowest in Bharat Immunologicals Biologicals Corporation share price₹ 12.3
1-Year % change in Bharat Immunologicals Biologicals Corporation share price-25.22%
1-Year Highest in Bharat Immunologicals Biologicals Corporation share price₹ 35.88
1-Year Lowest in Bharat Immunologicals Biologicals Corporation share price₹ 19

Top Mutual Funds Invested in Bharat Immunologicals Biologicals Corporation Share

Data is not available currently. Please check back later.

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,895.0Price decrease
-9.00 (-0.47%)
₹4,56,113.581,548.0 - 2,046.9
Divis Laboratories Ltd8,528.5Price decrease
-41.50 (-0.48%)
₹2,27,957.875,636.5 - 8,674.0
Torrent Pharmaceuticals Ltd4,901.0Price decrease
-104.00 (-2.08%)
₹1,89,989.943,480.6 - 5,250.0
Cipla Ltd1,426.5Price decrease
-11.50 (-0.80%)
₹1,16,141.011,165.7 - 1,673.0
Zydus Lifesciences Ltd1,111.8Price increase
4.10 (0.37%)
₹1,10,603.22835.5 - 1,205.0
Lupin Ltd2,195.0Price decrease
-6.50 (-0.30%)
₹1,00,732.901,875.0 - 2,529.5

Bharat Immunologicals Biologicals Corporation Ltd FAQs

Yes, You can buy Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) shares by opening a Demat account with Angel One.
Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) shares.

Open Free Demat Account!

Join our 3.8 Cr+ happy customers

+91
Top Gainers

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91